Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a new build of the page. No substantive content changes are reflected in this diff.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now states no longer looking for participants, indicating that recruitment is closed. Updated dates show primary completion on 2026-10-31 and study completion on 2028-02-29 to reflect the revised enrollment status.SummaryDifference4%

- Check33 days agoChange DetectedRevision: v3.6.5 is now shown, replacing Revision: v3.6.4. This indicates a new build of the page with no changes to the study details or visible features.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page shows a new Revision: v3.6.4 replacing the previous v3.6.3, indicating a minor software update to the ClinicalTrials.gov page. This likely reflects small fixes or updates to the site rather than substantive changes to the study details.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's revision tag was updated to v3.6.3, indicating a new release of the page or its backend. The update appears to be a metadata/maintenance change rather than a modification to study data.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now reflects the platform's new revision version, updating from v3.6.0 to v3.6.2. This represents a minor software release of the platform.SummaryDifference0.0%

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.